NanoSphere Health Sciences to report revenue and significant sales growth in Q2

|By:, SA News Editor

NanoSphere Health Sciences (OTC:NSHSF) exceeded growth projections for the quarter, multiple patents and new product releases have led to significant revenue for the company in Q2.

The Transdermal NanoSerum, stocked just under 200 dispensaries in Colorado, sold over 3,400 units in June, a 35% rise in sales from May 2018.

Press Release

Subscribe for full text news in your inbox